NCT02860819 2021-03-03Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell CancerNational Cancer Institute, SlovakiaPhase 2 Completed15 enrolled
NCT03403777 2019-03-05Avelumab in Refractory Testicular Germ Cell Cancer.National Cancer Institute, SlovakiaPhase 2 Completed8 enrolled